{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:35:30Z","timestamp":1787060130844,"version":"build-2736575974"},"reference-count":78,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"am","delay-in-days":337,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003762","name":"Institut Pasteur","doi-asserted-by":"publisher","award":["199038"],"award-info":[{"award-number":["199038"]}],"id":[{"id":"10.13039\/501100003762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006342","name":"Association Vaincre la Mucoviscidose","doi-asserted-by":"publisher","award":["RF20170502000\/1\/1\/141"],"award-info":[{"award-number":["RF20170502000\/1\/1\/141"]}],"id":[{"id":"10.13039\/501100006342","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Biology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jmb.2022.167929","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T11:16:40Z","timestamp":1671707800000},"page":"167929","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Design of Crotoxin-Based Peptides with Potentiator Activity Targeting the \u0394F508NBD1 Cystic Fibrosis Transmembrane Conductance Regulator"],"prefix":"10.1016","volume":"435","author":[{"given":"Marc","family":"Ravatin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Odolczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Servel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. I\u00f1aki","family":"Guijarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Tagat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Chevalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrine","family":"Baatallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Jean","family":"Corringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gergely L.","family":"Luk\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander","family":"Edelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Zielenkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Chambard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Hinzpeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazyna","family":"Faure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmb.2022.167929_b0005","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.jmb.2022.167929_b0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jcf.2008.03.009","article-title":"Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice","volume":"7","author":"Castellani","year":"2008","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.jmb.2022.167929_b0015","doi-asserted-by":"crossref","first-page":"eS4","DOI":"10.1016\/S0929-693X(20)30043-9","article-title":"Genetics of cystic fibrosis: Basics","volume":"27","author":"F\u00e9rec","year":"2020","journal-title":"Arch. Pediatr."},{"key":"10.1016\/j.jmb.2022.167929_b0020","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1126\/science.2570460","article-title":"Identification of the cystic fibrosis gene: genetic analysis","volume":"245","author":"Kerem","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.jmb.2022.167929_b0025","unstructured":"CFTR2 Variant List History | CFTR2, (n.d.). https:\/\/cftr2.org\/mutations_history (accessed July 29, 2022)."},{"key":"10.1016\/j.jmb.2022.167929_b0030","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis","volume":"388","author":"Elborn","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jmb.2022.167929_b0035","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/humu.10041","article-title":"Cystic fibrosis: A worldwide analysis of CFTR mutations\u2014correlation with incidence data and application to screening","volume":"19","author":"Bobadilla","year":"2002","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.jmb.2022.167929_b0040","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/MOG.0000000000000432","article-title":"Liver disease in patients with cystic fibrosis","volume":"34","author":"Kamal","year":"2018","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.jmb.2022.167929_b0045","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/mr.60.3.539-574.1996","article-title":"Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia","volume":"60","author":"Govan","year":"1996","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.jmb.2022.167929_b0050","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature04712","article-title":"The ABC protein turned chloride channel whose failure causes cystic fibrosis","volume":"440","author":"Gadsby","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2022.167929_b0055","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1042\/BST20150139","article-title":"ABC transporter research: going strong 40 years on","volume":"43","author":"Theodoulou","year":"2015","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.jmb.2022.167929_b0060","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nsmb.3216","article-title":"Mechanistic diversity in ATP-binding cassette (ABC) transporters","volume":"23","author":"Locher","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jmb.2022.167929_b0065","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1152\/physrev.00007.2018","article-title":"Structure, gating, and regulation of the CFTR anion channel","volume":"99","author":"Csan\u00e1dy","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jmb.2022.167929_b0070","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cell.2017.06.041","article-title":"Conformational Changes of CFTR upon Phosphorylation and ATP Binding","volume":"170","author":"Zhang","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2022.167929_b0075","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cell.2017.02.024","article-title":"Molecular Structure of the Human CFTR Ion Channel","volume":"169","author":"Liu","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2022.167929_b0080","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.biocel.2014.04.004","article-title":"Molecular modelling approaches for cystic fibrosis transmembrane conductance regulator studies","volume":"52","author":"Odolczyk","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jmb.2022.167929_b0085","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1152\/physrev.1999.79.1.S23","article-title":"Structure and Function of the CFTR Chloride Channel","volume":"79","author":"Sheppard","year":"1999","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jmb.2022.167929_b0090","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1126\/science.1704151","article-title":"Generation of cAMP-activated chloride currents by expression of CFTR","volume":"251","author":"Anderson","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.jmb.2022.167929_b0095","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.biocel.2014.04.001","article-title":"Understanding how cystic fibrosis mutations disrupt CFTR function: From single molecules to animal models","volume":"52","author":"Wang","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jmb.2022.167929_b0100","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1016\/S1569-1993(11)60018-0","article-title":"Pharmacological therapy for cystic fibrosis: From bench to bedside","volume":"10","author":"Becq","year":"2011","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.jmb.2022.167929_b0105","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009761","article-title":"Cystic Fibrosis Transmembrane Regulator Correctors and Potentiators","volume":"3","author":"Rowe","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.jmb.2022.167929_b0110","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.coph.2017.09.015","article-title":"CFTR potentiators: from bench to bedside","volume":"34","author":"Jih","year":"2017","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.jmb.2022.167929_b0115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jcf.2013.06.008","article-title":"Effect of ivacaftor on CFTR forms with missense mutations associated with defects in protein processing or function","volume":"13","author":"Van Goor","year":"2014","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.jmb.2022.167929_b0120","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation","author":"Ramsey","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmb.2022.167929_b0125","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1042\/BJ20071690","article-title":"Correctors promote folding of the CFTR in the endoplasmic reticulum","volume":"413","author":"Loo","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.jmb.2022.167929_b0130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1513\/AnnalsATS.201609-689OC","article-title":"VX09-809-102 Study Group, Lumacaftor\/Ivacaftor Treatment of Patients with Cystic Fibrosis Heterozygous for F508del-CFTR","volume":"14","author":"Rowe","year":"2017","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.jmb.2022.167929_b0135","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jcf.2017.09.012","article-title":"VX14-809-106 Investigator Group, Lumacaftor\/ivacaftor in patients with cystic fibrosis and advanced lung disease homozygous for F508del-CFTR","volume":"17","author":"Taylor-Cousar","year":"2018","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.jmb.2022.167929_b0140","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1056\/NEJMoa1709847","article-title":"Tezacaftor-Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis","volume":"377","author":"Rowe","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmb.2022.167929_b0145","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1056\/NEJMoa1709846","article-title":"Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del","volume":"377","author":"Taylor-Cousar","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmb.2022.167929_b0150","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"VX17-445-102 Study Group, Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmb.2022.167929_b0155","doi-asserted-by":"crossref","first-page":"11169","DOI":"10.1021\/acs.jmedchem.0c01050","article-title":"Identification, Structure-Activity Relationship, and Biological Characterization of 2,3,4,5-Tetrahydro-1H-pyrido[4,3-b]indoles as a Novel Class of CFTR Potentiators","volume":"63","author":"Brindani","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2022.167929_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112116","article-title":"Targeting different binding sites in the CFTR structures allows to synergistically potentiate channel activity","volume":"190","author":"Froux","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jmb.2022.167929_b0165","doi-asserted-by":"crossref","first-page":"17640","DOI":"10.1038\/s41598-019-54158-2","article-title":"Nanomolar-potency \u201cco-potentiator\u201d therapy for cystic fibrosis caused by a defined subset of minimal function CFTR mutants","volume":"9","author":"Phuan","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmb.2022.167929_b0170","doi-asserted-by":"crossref","first-page":"eaay9669","DOI":"10.1126\/sciadv.aay9669","article-title":"Discovery of a picomolar potency pharmacological corrector of the mutant CFTR chloride channel","volume":"6","author":"Pedemonte","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jmb.2022.167929_b0175","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jmb.2011.07.027","article-title":"Crystal Structure of Crotoxin Reveals Key Residues Involved in the Stability and Toxicity of This Potent Heterodimeric \u03b2-Neurotoxin","volume":"412","author":"Faure","year":"2011","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2022.167929_b0180","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/j.jmb.2016.05.016","article-title":"Rattlesnake Phospholipase A2 Increases CFTR-Chloride Channel Current and Corrects \u0394 F508CFTR Dysfunction: Impact in Cystic Fibrosis","volume":"428","author":"Faure","year":"2016","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2022.167929_b0185","doi-asserted-by":"crossref","first-page":"E5290","DOI":"10.3390\/molecules25225290","article-title":"Crystal Structure of Isoform CBd of the Basic Phospholipase A2 Subunit of Crotoxin: Description of the Structural Framework of CB for Interaction with Protein Targets","volume":"25","author":"Nemecz","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.jmb.2022.167929_b0190","series-title":"Toxins and Drug Discovery","first-page":"3","article-title":"Crotoxin from Crotalus durissus terrificus and Crotoxin-Related Proteins: Structure and Function Relationship","author":"Faure","year":"2017"},{"key":"10.1016\/j.jmb.2022.167929_b0195","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1093\/bioinformatics\/btr484","article-title":"COCOMAPS: a web application to analyze and visualize contacts at the interface of biomolecular complexes","volume":"27","author":"Vangone","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jmb.2022.167929_b0200","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nprot.2010.32","article-title":"The HADDOCK web server for data-driven biomolecular docking","volume":"5","author":"de Vries","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jmb.2022.167929_b0205","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jmb.2015.09.014","article-title":"The HADDOCK2.2 Web Server: User-Friendly Integrative Modeling of Biomolecular Complexes","volume":"428","author":"van Zundert","year":"2016","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2022.167929_b0210","doi-asserted-by":"crossref","first-page":"18825","DOI":"10.1073\/pnas.0904709106","article-title":"Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770","volume":"106","author":"Van Goor","year":"2009","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2022.167929_b0215","doi-asserted-by":"crossref","first-page":"18843","DOI":"10.1073\/pnas.1105787108","article-title":"Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809","volume":"108","author":"Van Goor","year":"2011","journal-title":"PNAS"},{"key":"10.1016\/j.jmb.2022.167929_b0220","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1056\/NEJMoa1807120","article-title":"VX-445\u2013Tezacaftor\u2013Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles","volume":"379","author":"Keating","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmb.2022.167929_b0225","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1091\/mbc.e13-05-0240","article-title":"VX-809 corrects folding defects in cystic fibrosis transmembrane conductance regulator protein through action on membrane-spanning domain 1","volume":"24","author":"Ren","year":"2013","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jmb.2022.167929_b0230","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1124\/mol.117.108373","article-title":"Direct Binding of the Corrector VX-809 to Human CFTR NBD1: Evidence of an Allosteric Coupling between the Binding Site and the NBD1:CL4 Interface","volume":"92","author":"Hudson","year":"2017","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jmb.2022.167929_b0235","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.139983","article-title":"Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combination","volume":"5","author":"Veit","year":"2020","journal-title":"JCI Insight."},{"key":"10.1016\/j.jmb.2022.167929_b0240","doi-asserted-by":"crossref","first-page":"7813","DOI":"10.1007\/s00018-021-03994-5","article-title":"Pharmacological chaperones improve intra-domain stability and inter-domain assembly via distinct binding sites to rescue misfolded CFTR","volume":"78","author":"Baatallah","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jmb.2022.167929_b0245","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cell.2021.12.009","article-title":"Mechanism of CFTR correction by type I folding correctors","volume":"185","author":"Fiedorczuk","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2022.167929_b0250","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1126\/science.aaw7611","article-title":"Structural identification of a hotspot on CFTR for potentiation","volume":"364","author":"Liu","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jmb.2022.167929_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113191","article-title":"Therapeutic peptides for the treatment of cystic fibrosis: Challenges and perspectives","volume":"213","author":"Sala","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jmb.2022.167929_b0260","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00018-021-04030-2","article-title":"Esc peptides as novel potentiators of defective cystic fibrosis transmembrane conductance regulator: an unprecedented property of antimicrobial peptides","volume":"79","author":"Ferrera","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jmb.2022.167929_b0265","doi-asserted-by":"crossref","first-page":"5364","DOI":"10.1074\/jbc.M709417200","article-title":"Mechanism of G551D-CFTR (cystic fibrosis transmembrane conductance regulator) potentiation by a high affinity ATP analog","volume":"283","author":"Bompadre","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2022.167929_b0270","doi-asserted-by":"crossref","first-page":"37663","DOI":"10.1074\/jbc.M110.172817","article-title":"Optimization of the degenerated interfacial ATP binding site improves the function of disease-related mutant cystic fibrosis transmembrane conductance regulator (CFTR) channels","volume":"285","author":"Tsai","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2022.167929_b0275","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1113\/jphysiol.2005.095083","article-title":"High affinity ATP\/ADP analogues as new tools for studying CFTR gating","volume":"569","author":"Zhou","year":"2005","journal-title":"J. Physiol."},{"key":"10.1016\/j.jmb.2022.167929_b0280","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0014-5793(02)02698-4","article-title":"Nucleoside triphosphate pentose ring impact on CFTR gating and hydrolysis","volume":"518","author":"Aleksandrov","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jmb.2022.167929_b0285","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1074\/jbc.M510576200","article-title":"Differential sensitivity of the cystic fibrosis (CF)-associated mutants G551D and G1349D to potentiators of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel","volume":"281","author":"Cai","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2022.167929_b0290","doi-asserted-by":"crossref","first-page":"19967","DOI":"10.1074\/jbc.M109.092684","article-title":"Potentiation of disease-associated cystic fibrosis transmembrane conductance regulator mutants by hydrolyzable ATP analogs","volume":"285","author":"Miki","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2022.167929_b0295","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s004240050424","article-title":"Direct action of genistein on CFTR","volume":"434","author":"Weinreich","year":"1997","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.jmb.2022.167929_b0300","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/sj.bjp.0707663","article-title":"Prolonged treatment of cells with genistein modulates the expression and function of the cystic fibrosis transmembrane conductance regulator","volume":"153","author":"Schmidt","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jmb.2022.167929_b0305","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s00018-004-4422-3","article-title":"Binding site of activators of the cystic fibrosis transmembrane conductance regulator in the nucleotide binding domains","volume":"62","author":"Moran","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jmb.2022.167929_b0310","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jcf.2019.10.011","article-title":"Mutation-specific dual potentiators maximize rescue of CFTR gating mutants","volume":"19","author":"Veit","year":"2020","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.jmb.2022.167929_b0315","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/19336950.2015.1126010","article-title":"Potential sites of CFTR activation by tyrosine kinases","volume":"10","author":"Billet","year":"2016","journal-title":"Channels (Austin)"},{"key":"10.1016\/j.jmb.2022.167929_b0320","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jcmgh.2019.09.003","article-title":"Regulation of CFTR Bicarbonate Channel Activity by WNK1: Implications for Pancreatitis and CFTR-Related Disorders","volume":"9","author":"Kim","year":"2020","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jmb.2022.167929_b0325","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cell.2011.11.024","article-title":"Correction of both NBD1 energetics and domain interface is required to restore \u0394F508 CFTR folding and function","volume":"148","author":"Rabeh","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2022.167929_b0330","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmb.2022.167929_b0335","doi-asserted-by":"crossref","first-page":"W362","DOI":"10.1093\/nar\/gkl124","article-title":"ScanProsite: detection of PROSITE signature matches and ProRule-associated functional and structural residues in proteins","volume":"34","author":"de Castro","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmb.2022.167929_b0340","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1021\/acs.jcim.5b00529","article-title":"Combination of Ambiguous and Unambiguous Data in the Restraint-driven Docking of Flexible Peptides with HADDOCK: The Binding of the Spider Toxin PcTx1 to the Acid Sensing Ion Channel (ASIC) 1a","volume":"56","author":"Deplazes","year":"2016","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmb.2022.167929_b0345","series-title":"Modeling Peptide-Protein Interactions: Methods and Protocols","first-page":"109","article-title":"Information-Driven, Ensemble Flexible Peptide Docking Using HADDOCK","author":"Geng","year":"2017"},{"key":"10.1016\/j.jmb.2022.167929_b0350","doi-asserted-by":"crossref","first-page":"30563","DOI":"10.1074\/jbc.272.48.30563","article-title":"Cystic fibrosis phenotype associated with pancreatic insufficiency does not always reflect the cAMP-dependent chloride conductive pathway defect. Analysis of C225R-CFTR and R1066C-CFTR","volume":"272","author":"Fanen","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2022.167929_b0355","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/emmm.201302699","article-title":"Discovery of novel potent \u0394F508-CFTR correctors that target the nucleotide binding domain","volume":"5","author":"Odolczyk","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jmb.2022.167929_b0360","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/jmi.12069","article-title":"Quick-and-clean article figures with FigureJ","volume":"252","author":"Mutterer","year":"2013","journal-title":"J. Microsc."},{"issue":"1990","key":"10.1016\/j.jmb.2022.167929_b0365","first-page":"177","article-title":"Rapid-pulsing artifacts in double-quantum-filtered COSY","volume":"88","author":"Derome","year":"1969","journal-title":"J. Magn. Reson."},{"issue":"1982","key":"10.1016\/j.jmb.2022.167929_b0370","first-page":"286","article-title":"A two-dimensional nuclear overhauser experiment with pure absorption phase in four quadrants","volume":"48","author":"States","year":"1969","journal-title":"J. Magn. Reson."},{"key":"10.1016\/j.jmb.2022.167929_b0375","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1002\/anie.200351947","article-title":"Elimination of Zero-Quantum Interference in Two-Dimensional NMR Spectra","volume":"42","author":"Thrippleton","year":"2003","journal-title":"Angew. Chem. Int. Ed."},{"issue":"1985","key":"10.1016\/j.jmb.2022.167929_b0380","first-page":"207","article-title":"Practical aspects of two-dimensional transverse NOE spectroscopy","volume":"63","author":"Bax","year":"1969","journal-title":"J. Magn. Reson."},{"key":"10.1016\/j.jmb.2022.167929_b0385","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1021\/ja0100120","article-title":"Group Epitope Mapping by Saturation Transfer Difference NMR To Identify Segments of a Ligand in Direct Contact with a Protein Receptor","volume":"123","author":"Mayer","year":"2001","journal-title":"J. Am. Chem. Soc."},{"issue":"1991","key":"10.1016\/j.jmb.2022.167929_b0390","first-page":"93","article-title":"Band-selective radiofrequency pulses","volume":"93","author":"Geen","year":"1969","journal-title":"J. Magn. Reson."}],"container-title":["Journal of Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283622005563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283622005563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T06:26:29Z","timestamp":1762669589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022283622005563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":78,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0022283622005563"],"URL":"https:\/\/doi.org\/10.1016\/j.jmb.2022.167929","relation":{},"ISSN":["0022-2836"],"issn-type":[{"value":"0022-2836","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design of Crotoxin-Based Peptides with Potentiator Activity Targeting the \u0394F508NBD1 Cystic Fibrosis Transmembrane Conductance Regulator","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmb.2022.167929","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"167929"}}